Yttrium-90 (BioDeep_00000837904)
代谢物信息卡片
化学式: Y (88.905856)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: [Y]
InChI: InChI=1S/Y/i1+1
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- Bernhard Nilica, Anna Svirydenka, Josef Fritz, Steffen Bayerschmidt, Alexander Kroiss, Leonhard Gruber, Irene Johanna Virgolini. Nephrotoxicity and hematotoxicity one year after four cycles of peptide receptor radionuclide therapy (PRRT) and its impact on future treatment planning - A retrospective analysis.
Revista espanola de medicina nuclear e imagen molecular.
2022 May; 41(3):138-145. doi:
10.1016/j.remnie.2021.04.007
. [PMID: 35577489] - Antonino Amato, Pier Luigi Carriero, Gordon McVie, Giovanni Paganelli. A Novel Injectable Hydrogel Matrix Loaded With 90Y Microspheres for the Treatment of Solid Tumors.
Anticancer research.
2022 Feb; 42(2):827-836. doi:
10.21873/anticanres.15540
. [PMID: 35093880] - Teresa Scotognella, Daria Maccora, Isabella Bruno, Marco Chinol, Massimo Castagnola, Francesco Collamati, Carlo Mancini-Terraciano, Silvio Morganti, Valerio Bocci, Elena Solfaroli Camillocci, Dante Rotili, Antonella Cartoni, Ilaria Fratoddi, Federica Marini, Iole Venditti, Riccardo Faccini, Alessandro Giordano. 90Y-DOTA-Nimotuzumab: Synthesis of a Promising β- Radiopharmaceutical.
Current radiopharmaceuticals.
2022; 15(1):32-39. doi:
10.2174/1874471013999210104220031
. [PMID: 33397277] - Hyun-Soon Chong, Yunwei Chen, Chi Soo Kang, Inseok Sin, Shuyuan Zhang, Haixing Wang. Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with 177Lu(III) and 90Y(III) for radiopharmaceutical applications: Synthesis, DFT calculation, radiolabeling, and in vitro complex stability.
Journal of inorganic biochemistry.
2021 08; 221(?):111436. doi:
10.1016/j.jinorgbio.2021.111436
. [PMID: 33971521] - Magda Zadrozny, Nathalie Hainzer, Julinda Mehilli, David Jochheim, Sarah Gschwendtner, Julius Steffen, Hans Theiss, Daniel Braun, Christian Hagl, Sebastian Sadoni, Steffen Massberg, Joerg Hausleiter, Simon Deseive. TAVR in nonagenarians: An analysis investigating safety, efficacy, symptomatic improvement, and long-term survival.
Journal of cardiology.
2021 07; 78(1):44-50. doi:
10.1016/j.jjcc.2021.01.016
. [PMID: 33563507] - Darrell R Fisher. Radiation Safety for Yttrium-90-polymer Composites (RadioGel™) in Therapy of Solid Tumors.
Health physics.
2021 05; 120(5):510-516. doi:
10.1097/hp.0000000000001369
. [PMID: 33760767] - E Courtney Henry, Matthew Strugari, George Mawko, Kimberly D Brewer, Robert Abraham, S Cheenu Kappadath, Alasdair Syme. Post-administration dosimetry in yttrium-90 radioembolization through micro-CT imaging of radiopaque microspheres in a porcine renal model.
Physics in medicine and biology.
2021 04; 66(9):. doi:
10.1088/1361-6560/abf38a
. [PMID: 33784639] - Chien-An Liu, I-Cheng Lee, Rheun-Chuan Lee, Jian-Ling Chen, Yee Chao, Ming-Chih Hou, Yi-Hsiang Huang. Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres.
Journal of the Formosan Medical Association = Taiwan yi zhi.
2021 Apr; 120(4):1127-1136. doi:
10.1016/j.jfma.2020.09.005
. [PMID: 32978044] - Arpit Mitra, Avik Chakraborty, Sujay Gaikwad, Megha Tawate, Trupti Upadhye, Sangita Lad, Sudip Sahoo, Poonam Jagesia, Rahul Parghane, Sreeja Menon, Sandip Basu, Prem Singh Dhami, Sharmila Banerjee. On the Separation of Yttrium-90 from High-Level Liquid Waste: Purification to Clinical-Grade Radiochemical Precursor, Clinical Translation in Formulation of 90Y-DOTATATE Patient Dose.
Cancer biotherapy & radiopharmaceuticals.
2021 Mar; 36(2):143-159. doi:
10.1089/cbr.2020.4092
. [PMID: 33750229] - Kevin P Labadie, Andrew D Ludwig, Adrienne L Lehnert, Donald K Hamlin, Aimee L Kenoyer, Kevin M Sullivan, Sara K Daniel, Tara N Mihailovic, Jonathan G Sham, Johnnie J Orozco, Raymond S Yeung, Delphine L Chen, D Scott Wilbur, Robert S Miyaoka, James O Park. Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma.
Scientific reports.
2021 02; 11(1):3731. doi:
10.1038/s41598-021-82172-w
. [PMID: 33580090] - Yuichi Funase, Eri Nakamura, Masamichi Kajita, Yasutaka Saito, Shinobu Oshikiri, Michi Kitano, Masahiko Tokura, Akihiro Hino, Tomoya Uehara. Preclinical Characterization of the Radioimmunoconjugate 111In or 90Y-FF-21101 Against a P-Cadherin-Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2021 02; 62(2):232-239. doi:
10.2967/jnumed.120.245837
. [PMID: 32737245] - Vivek Subbiah, William Erwin, Osama Mawlawi, Asa McCoy, David Wages, Catherine Wheeler, Carlos Gonzalez-Lepera, Holly Liu, Homer Macapinlac, Funda Meric-Bernstam, David S Hong, Shubham Pant, Dao Le, Elmer Santos, Jose Gonzalez, Jason Roszik, Takeaki Suzuki, Ruth Ann Subach, Timothy Madden, Mary Johansen, Fumiko Nomura, Hirokazu Satoh, Tadashi Matsuura, Masamichi Kajita, Eri Nakamura, Yuichi Funase, Satoshi Matsushima, Gregory Ravizzini. Phase I Study of P-cadherin-targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020 11; 26(22):5830-5842. doi:
10.1158/1078-0432.ccr-20-0037
. [PMID: 32816889] - Neal Bhutiani, Stephen J O'Brien, Erin E Priddy, Michael E Egger, Young K Hong, Megan K Mercer, Kelly M McMasters, Robert C G Martin, Melissa H Potts, Charles R Scoggins. Correlating serum alpha-fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere™).
HPB : the official journal of the International Hepato Pancreato Biliary Association.
2020 09; 22(9):1330-1338. doi:
10.1016/j.hpb.2019.12.007
. [PMID: 31917103] - Cati Raluca Stolniceanu, Ionut Nistor, Stefana Catalina Bilha, Volovat Constantin, Volovat Simona, Milovan Matovic, Cipriana Stefanescu, Adrian Covic. Nephrotoxicity/renal failure after therapy with 90Yttrium- and 177Lutetium-radiolabeled somatostatin analogs in different types of neuroendocrine tumors: a systematic review.
Nuclear medicine communications.
2020 Jul; 41(7):601-617. doi:
10.1097/mnm.0000000000001198
. [PMID: 32404645] - David Akhavan, Paul Yazaki, Dave Yamauchi, Jennifer Simpson, Paul H Frankel, James Bading, David Colcher, Kofi Poku, Yi-Jen Chen, Dean Lim, Mihaela Cristea, Anna Wu, John Shively, Jeffrey Y C Wong. Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies.
Cancer biotherapy & radiopharmaceuticals.
2020 Feb; 35(1):10-15. doi:
10.1089/cbr.2019.2992
. [PMID: 31910346] - Hendrik Rathke, Paul Flechsig, Walter Mier, Marcus Bronzel, Eleni Mavriopoulou, Markus Hohenfellner, Frederik Lars Giesel, Uwe Haberkorn, Clemens Kratochwil. Dosimetry Estimate and Initial Clinical Experience with 90Y-PSMA-617.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2019 Jun; 60(6):806-811. doi:
10.2967/jnumed.118.218917
. [PMID: 30389816] - Fu Yugui, Hailan Wang, Dezhong Sun, Xiaoyan Zhang. Nasopharyngeal cancer combination chemoradiation therapy based on folic acid modified, gefitinib and yttrium 90 co-loaded, core-shell structured lipid-polymer hybrid nanoparticles.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
2019 Jun; 114(?):108820. doi:
10.1016/j.biopha.2019.108820
. [PMID: 30951947] - Marija Z Jeremic, Milovan D Matovic, Dragana Z Krstic, Suzana B Pantovic, Dragoslav R Nikezic. A five-compartment biokinetic model for 90 Y-DOTATOC therapy.
Medical physics.
2018 Dec; 45(12):5577-5585. doi:
10.1002/mp.13229
. [PMID: 30291717] - Robert Zwolak, Maria Majdan. [Methods of efficacy assessment of the knee joint radiosynoviorthesis- personal experience].
Wiadomosci lekarskie (Warsaw, Poland : 1960).
2018 ; 71(1 pt 1):10-16. doi:
NULL
. [PMID: 29558346] - Agnieszka Kolasińska-Ćwikła, Anna Łowczak, Katarzyna Maciejkiewicz Maciejkiewicz, Jarosław Bogdan Ćwikła. Peptide Receptor Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors - from oncology perspective.
Nuclear medicine review. Central & Eastern Europe.
2018; 21(2):. doi:
10.5603/nmr.2018.0019
. [PMID: 29741203] - Oliver S Grosser, Juri Ruf, Annette Pethe, Dennis Kupitz, Heiko Wissel, Christoph Benckert, Maciej Pech, Jens Ricke, Holger Amthauer. Urinary Excretion of Yttrium-90 after Radioembolization with Yttrium-90-Labeled Resin-based Microspheres.
Health physics.
2018 01; 114(1):58-63. doi:
10.1097/hp.0000000000000734
. [PMID: 29049048] - Susanna Tribuzi, Alessia Naccarato, Lorella Pelagalli, Marco Covotta, Giulia Torregiani, Claudia Claroni, Ester Forastiere. Acquired Hemophilia A After Hepatic Yttrium-90 Radioembolization: A Case Report.
A & A case reports.
2017 Dec; 9(12):344-345. doi:
10.1213/xaa.0000000000000611
. [PMID: 28767473] - Hikaru Amano, Hideaki Sakamoto, Norikatsu Shiga, Kaori Suzuki. Method for rapid screening analysis of Sr-90 in edible plant samples collected near Fukushima, Japan.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
2016 06; 112(?):131-5. doi:
10.1016/j.apradiso.2016.03.026
. [PMID: 27043171]